Digital Health: Page 13
-
ResMed closes $1B Medifox buyout to expand software business into Europe
The takeover gives ResMed control of a 700-person operation that offers similar solutions to its existing U.S. brands MatrixCare and Brightree.
By Nick Paul Taylor • Nov. 23, 2022 -
State AGs urge Apple to protect consumers’ reproductive health data
Apps holding sensitive health data should be required to delete nonessential information and clearly inform consumers what information they share with parties such as law enforcement, the 10 state attorneys general said.
By Rebecca Pifer Parduhn • Nov. 22, 2022 -
Apple earbuds show promise as hearing aids in clinical trial
The earbuds performed comparably to hearing aids in terms of speech perception in quiet environments.
By Nick Paul Taylor • Nov. 22, 2022 -
Deep Dive
Health tech companies weigh options to stem cash burn as IPO market sags
Healthcare technology companies are delaying initial share sales as public market stocks and valuations plunge across the sector. Where will they turn in the meantime?
By Sydney Halleman • Updated Nov. 24, 2022 -
Apple Watch app for monitoring Parkinson’s symptoms earns FDA clearance
The technology has been validated in a clinical trial, positioning h2o to create an app that enables real-time sharing of Parkinson’s symptom data.
By Nick Paul Taylor • Nov. 21, 2022 -
How wearable devices with skin-like stretchability may pave way for better health tracking
An AI-enabled prototype based on the stretchable technology was more than 95% effective at correctly identifying electrocardiogram signals.
By Nick Paul Taylor • Nov. 21, 2022 -
AEYE Health wins FDA clearance for AI-powered eye test to expand diabetic screening
Approval is a first step to letting primary care physicians use a hand-held camera backed by AI to diagnose potential diabetic-related sight issues.
By Nick Paul Taylor • Nov. 18, 2022 -
Penumbra expands VR rehabilitation platform with lower body sensors
Adding lower body sensors will enable the company to target a wider range of health conditions.
By Nick Paul Taylor • Nov. 16, 2022 -
Pear Therapeutics undergoes another round of layoffs, cutting 22% of staff
The digital therapeutics company said the reductions will extend its cash runway and curb its reliance on financing.
By Elise Reuter • Nov. 15, 2022 -
NFL expands program to use sensor-loaded mouthguards to gather head impact data
Data from the sensors could show what the human head experiences during an impact, improving efforts to reduce the incidence of concussions in football.
By Nick Paul Taylor • Nov. 15, 2022 -
ResMed, Google sibling Verily form digital health venture to improve access to sleep treatment
Primasun will use an app to diagnose and treat obstructive sleep apnea and evaluate patients with insomnia symptoms.
By Nick Paul Taylor • Nov. 15, 2022 -
Tandem pump, paired with Dexcom CGM, boosts blood glucose control in Type 2 diabetics
Patients with Type 2 diabetes spent 3.6 hours per day longer in the target blood glucose range after switching to Tandem’s system, a study found.
By Nick Paul Taylor • Nov. 14, 2022 -
Mayo Clinic creates product to test AI models for bias and inaccuracy
The proliferation of AI models has led to concerns about whether they work as intended.
By Nick Paul Taylor • Nov. 14, 2022 -
Q&A
Friday Q&A: GE HealthCare’s Shetty on building accurate AI tools
The executive, who leads the company’s effort to create an integrated suite of AI tools for hospitals, warns against overloading clinicians with unconnected information.
By Elise Reuter • Nov. 11, 2022 -
Medtech execs ‘rethink’ long-term strategies as care settings shift: Accenture report
The move from hospitals to ambulatory and at-home care is only just beginning, the survey found.
By Nick Paul Taylor • Nov. 10, 2022 -
Affordable alternative: Smartphone-based hearing test for infants targets developing countries
The off-the-shelf alternative has a material cost of $10, giving children in impoverished regions easier access to vital monitoring and diagnosis.
By Nick Paul Taylor • Nov. 9, 2022 -
Lilly’s new diabetes management platform to integrate Dexcom CGM
The launch comes seven years after the company began investing in device R&D to counter pricing pressures.
By Nick Paul Taylor • Nov. 9, 2022 -
Verily’s Onduo cut blood sugar in retrospective study of Type 2 diabetics
Participants with high blood sugar at baseline benefited the most from Onduo, a study found.
By Nick Paul Taylor • Nov. 8, 2022 -
5 takeaways from the FDA’s list of AI-enabled medical devices
As the number of devices increases, the agency is looking to adapt its regulatory framework to the new technology, including faster approval of algorithm updates.
By Elise Reuter • Nov. 7, 2022 -
iRhythm narrowed loss in Q3 on higher sales of cardiac wearables
Revised CMS reimbursement rates may boost the earnings potential for the company’s wearable heart monitors.
By Peter Green • Updated Nov. 4, 2022 -
Baxter warns hospitals to stop using connected incontinence pads over interference risk
The interference may affect insulin pumps, fetal monitors, telemetry devices, bladder scanners and infusion pumps.
By Nick Paul Taylor • Oct. 27, 2022 -
BioIntelliSense buys AlertWatch, expanding Medtronic patient monitoring partnership
Medtronic will distribute AlertWatch to hospitals in the U.S. alongside BioIntelliSense’s wearable device for continuous remote monitoring.
By Nick Paul Taylor • Oct. 25, 2022 -
FDA moves to make effect on health equity part of breakthrough device considerations
If it finalizes the proposal, the agency will expand its breakthrough program to devices that improve accessibility.
By Nick Paul Taylor • Oct. 21, 2022 -
GE forms pact with AMC Health to enable more remote monitoring in home care
As costs of caring for chronic disease rise and hospital staffing remains a challenge, home care remotely monitored by clinicians is emerging as a cost-saving frontier.
By Nick Paul Taylor • Oct. 20, 2022 -
FDA seeks feedback on plans to draft and finalize medical device guidance in 2023
The agency’s review includes guidance on transitioning away from emergency use authorizations, while abandoning plans for guidance on software as a medical device.
By Nick Paul Taylor • Oct. 19, 2022